Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZALEA: CLS-TA in non-infectious uveitis
NCT03097315Phase 3Completed
- Sponsor
- Clearside Biomedical
- Start
- Apr 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in noninfectious uveitis (NIU), sponsored by Clearside Biomedical. Started Apr 2017; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT03097315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03097315.